The growth of the human population has profoundly affected the global ecosystem, influencing the animal population balance, the availability of fresh water, arable land, biotic production, and atmospheric gases. The human ecological impact has significantly accelerated the evolutionary change of numerous organisms. For example, the production of human medicine and food has resulted in the rapid evolution of drug-resistant pathogenic organisms as well as plants and insects resistant to pesticides (Palumbi, 2001). Recently, the nutritional support of the human population has relied on the vast monoculture of domestic mammals and birds, which has facilitated the emergence of pathogenic enzootic organisms that infect both animals and humans. This chapter will focus on the global threat to human health represented by the highly contagious enzootic virus influenza. It will also discuss current efforts and future improvements to protect humans from global influenza epidemics and pandemics.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Almond, J. W. (1977). A single gene determines the host range of influenza. Nature, 270, 617–618
Alexander, D.J. (2000). A Review of avian influenza in different bird species. Veterinary Microbiology 74, 3–13
Baigent, S. J., & McCauley, J. W. (2003). Influenza type A in humans, mammals and birds: Determinants of virus host-range and interspecies transmission. BioEssays, 25, 657–671
Banks, J., Speidel, E. C., McCauley, J. W., & Alexander, D. J. (2000). Phylogenetic analysis of H7 hemagglutinin subtype influenza A viruses. Archives of Virology, 145, 1047–1058
Banks, J., Speidel, E. C., Moore, E., Plowright, L., Piccirillo, A., Capua, I., Cordioli, P., Fioretti, A., & Alexander, D. J. (2001). Changes in the hemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Archives of Virology, 146, 963–973
Barry, J. M. (2004). The Great Influenza. Penguin, Harmondsworth
Barry, D. W., Mayner, R. E., Meisler, J. M., & Seligmann Jr., E. B. (1977). Evaluation and control of vaccines for the National Influenza Immunization Program. Journal of Infectious Diseases, 136, S407–S414
Bean, W. J., & Webster, R. G. (1978). Phenotypic properties associated with influenza genome segments. In Negative Strand Viruses and the Host Cell (Mahy, B. W. J., & Barry, R. D., Eds), pp. 685–692. Academic, London
Black, R. A., Rota, P. A., Gorodkova, N., Klenk, H. D., & Kendal, A. P. (1993). Antibody response of the M2 protein of influenza A virus expressed in insect cells. Journal of General Virology, 74, 143–146
Bright, R. A., Shay, D. K., Shu, B., Cox, N. J., & Klimov, A. I. (2006). Adamatane resistance among Influenza A viruses isolated early during the 2005–2006 influenza season in the United States. JAMA, 295(8), 891–894
Brown, F., Robertson, J. S., Schild, G. C., & Wood, J. M. (1999). Inactivated influenza vaccines prepared in cell culture. Developments in Biological Standardization, 98
Brugha, R., Sterling, M., & Walt, G. (2002). GAVI, the first steps: Lessons for the Global Fund. Lancet, 359, 435–438
Capua, I., & Alexander, D. J. (2004). Avian influenza: Recent developments. Avian Pathology, 33, 393–404
Capua, I., & Marangon, S. (2000). The avian influenza epidemic in Italy, 1999–2000: a review. Avian Pathology, 29, 289–294
Chen, H., Smith, G. J. D., Zhang, S. Y., Qin, K., Wang, J., Li, K. S., Webster, R. G., Peiris, J. S. M., & Guan, Y. (2005). H5N1 virus outbreak in migratory waterfowl. Nature, 436, 191–192
Cleaveland, S., Laurenson, M. K., & Taylor, L. H. (2001). Diseases of humans and their domestic mammals: Pathogen characteristics, host range and the risk of emergence. Philosophical Transactions of the Royal Society of London. Series B, 356, 991–999
Connor, R. J., Kawaoka, Y., Webster, R. G., & Paulson, J. C. (1994). Receptor specificity in human, avian and equine H2 and H3 influenza isolates. Virology, 205, 17–23
Cox, N. J., & Subbarao, K. (2000). Global epidemiology of influenza: Past and present. Annual Reviews of Medicine, 51, 407–421
Daly, J. M., Newton, J. R., & Mumford, J. A. (2004). Current perspectives on control of equine influenza. Veterinary Research, 35, 411–423
Epstein, S. L., Tumpey, T. M., Misplon, J. A., Lo, C-Y., Cooper, L. A., Subbarao, K., Renshaw, M., Sambhara, S., & Katz, J. M. (2002). DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerging Infectious Diseases, 8, 796–801
Fan, J., Liang, X., Horton, M. S., Perry, H. C., Citron, M. P., Heidecker, G. J., Fu, T-M., Joyce, J., Przysiecki, C. T., Keller, P. M., Garsky, V. M., Ionescu, R., Rippeon, Y., Shi, L., Chastain, M. A., Condra, J. H., Davies, M-E., Liao, J., Emini, E. A., & Shiver, J. W. (2004). Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets and rhesus monkeys. Vaccine, 22, 2993–3003
Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., & Burke, D. S. (2005). Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature, 437, 209–214
Fiers, W., De Filette, M., Birkett, A., Nierynck, S., & Min Jou, W. (2004). A universal influenza A vaccine. Virus Research, 103, 173–176
Fouchier, R. A. M., Osterhaus, A. D. M. E., & Brown, I. H. (2003). Animal influenza virus surveillance. Vaccine, 21, 1754–1757
Francis Jr., T., Salk, J. E., & Quilligan, J. J. J. (1947). Experience with vaccination against influenza in the spring of 1947. American Journal of Public Health, 37, 1013–1016
Gambaryan, A. S., Piskarev, V. E., Yamskov, I. A., Sakharov, A. M., Tuzikov, A. B., Bovin, N. V., Nifant’ev, N. E., & Matrosovich, M. N. (1995). Human influenza virus recognition of oligosaccharides. FEBS Letters, 366, 57–60
Garcia, M., Crawford, J. M., Latimer, J. W., RiveraCruz, E., & Perdue, M. L. (1996). Heterogeneity in the hemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza strains in Mexico. Journal of General Virology, 77, 1493–1504
Garrett, L. (1994). The Coming Plague: Newly Emerging Diseases in a World Out of Balance. Farrar, Strauss and Giroux, New York
Ghedin, E., Sengamalay, N. A., Shumway, M., Zaborsky, J., Feldblyum, T., Subbu, V., Spiro, D. J., Sitz, J., Koo, H., Bolotov, P., Dernovoy, D., Tatusova, T., Bao, Y., St George, K., Taylor, J. U., Lipman, D. J., Fraser, C. M., Taubenberger, J. K., & Salzberg, S. L. (2005). Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature, 437, 1162–1166
Glezen, W.P. (1996) Emerging Infections: Pandemic Influenza. Epidemiologic Reviews 18(1), 64–76
Harvey, R., Martin, A. C. R., Zambon, M., & Barclay, W. S. (2004). Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. Journal of Virology, 78, 502–507
Hayden, F., & Croisier, A. (2005). Transmission of avian influenza viruses to and between humans. Journal of Infectious Diseases, 192, 1311–1314
Helenius, A. (1992). Unpacking the incoming influenza virus. Cell, 69, 577–578
Hilleman, M. R. (1999). Personal historical chronicle of six decades of basic and applied research in virology, immunology and vaccinology. Immunological Reviews, 170, 7–27
Hinshaw, V. S., Webster, R. G., & Turner, B. (1980). The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl, Journal of Microbiology, 26, 622–629
Horimoto, T., & Kawaoka, Y. (2001). Pandemic threat posed by avian influenza A viruses. Clinical Microbiology Reviews, 14, 129–149
Ionescu, R. M., Przysiecki, C. T., Liang, X., Garsky, V. M., Fan, J., Wang, B., Troutman, R., Pippeon, Y, Flanagan, E., Shiver, J., & Shi, L. (2006). Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. Journal of Pharmaceutical Science, 95, 70–79
Ito, T., Gorman, O. T., Kawaoka, Y., Bean, W. J., & Webster, R. G. (1991). Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins. Journal of Virology, 65, 5491–5498
Karasin, A. I., Olsen, C. W., & Anderson, G. A. (2000). Genetic characterization of an H1N2 influenza isolated from a pig in Indiana. Journal of Clinical Microbiology, 38, 2453–2456
Kawaoka, Y., Krauss, S., & Webster, R. G. (1989). Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. Journal of Virology, 63, 4603–4608
Koen, J. S. (1919). A practical method for field diagnosis of swine diseases. American Journal of Veterinary Medicine, 14, 468–470
Lamb, R. A., Zebedee, S. L., & Richardson, C. D. (1985). Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell, 40, 627–633
Le, Q. M., Kiso, M., Someya, K., Sakai, Y., Nguyen, T, H., Nguyen, K. H. L., Dinh Pham, N., Nguyen, H. N., Yamada, S., Muramoto, Y. Horimoto, T., Takada, A., Goto, H. Suzuki, T., Suzuki, Y., & Kawaoka, Y. (2005). Isolation of drug resistant H5N1 virus. Nature, 437, 1108
Levi, R., & Arnon, R. (1996). Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross strain protection. Vaccine, 14, 85–92
Liu, W., Peng, Z., Liu, Z., Lu, Y., Ding, J., & Chen, Y-H. (2004). High epitope density in a single recombinant protein molecule of the extracellular domain of influenza A virus M2 protein significantly enhances protective immunity. Vaccine, 23, 366–371
Longini, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T., & Halloran, M. E. (2005). Containing pandemic influenza at the source. Science, 309, 1083–1087
Luk, J., Gross, P., & Thompson, W. W. (2001). Observations on mortality during the 1918 influenza pandemic. Clinical Infectious Diseases, 33, 1375–1378
Maassab, H. F., & Bryant, M. L. (1999). The development of live attenuated cold adapted influenza virus vaccine for humans. Reviews in Medical Virology, 9, 237–244
Matrosovitch, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M. R., Donatelli, I., & Kawaoka, Y. (2000). Early alterations of the receptor-binding properties of H1, H2 and H3 avian influenza virus hemagglutinins after their introduction into mammals. Journal of Virology, 74, 8502–8512
McMichael, A. J. (2004). Environmental and social influences on emerging infectious diseases: Past, present and future. Philosophical Transactions of the Royal Society of London. Series B, 359, 1049–1058
Mozdzanowska, K., Feng, J. Q., Eid, M., Kragol, G., Cudic, M., Otvos, L., & Gerhard, W. (2003). Induction of Influenza type A virus specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine, 21, 2616–2626
Murphy, F. A. (1996). Virus taxonomy. In Virology (Fields, B. N., Knipe, D. M. & Howley, P. M., Eds.), pp. 15–57, Lippincott-Raven, Philadelphia
Murray, R. (1969). Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1868–69. Bulletin of the World Health Organization, 41, 495–496
Naeem, K. (1998). The avian influenza outbreak in South Central Asia. In Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists. Pennsylvania, Athens, Georgia, USA, pp. 31–35
Nierynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Min Lou, W., & Fiers, W. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nature Medicine, 5, 1157–1163
Nobusawa, E., Ishihara, H., Morishita, T., Sato, K., & Nakajima, K. (2000). Change in receptor-binding specificity of recent human influenza A viruses (H3N2): A single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology, 278, 587–596
Obenauer, J. C., Denson, J., Mehta, P. K., Su, X., Mukatira, S., Finkelstein, D. B., Xu, X., Wang, J., Ma, J., Fan, Y., Rakestraw, K. M., Webster, R. G., Hoffman, E., Krauss, S., Zheng, J., Zhang, Z., & Naeve, C. W. (2006). Large-scale sequence analysis of avian influenza isolates. Science, 311, 1576–1580
Oxford, J. S., McGeoch, D. J., Schild, G. C., & Beare, A. S. (1978). Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature, 273, 778–779
PAHO Meeting. (2005). Avian Influenza and Pandemic Preparedness: The Vaccine Industry Perspective. Washington, DC, 21 November 2005
Palumbi, S.R. (2001). Humans as the world’s greatest evolutionary force. Science. 293, 5536, 1786–1790
Payne, A. M. (1953). The influenza programme of WHO. Bulletin of the World Health Organization, 8, 755–774
Perdue, M., Crawford, J., Garcia, M., Latimer, J., & Swayne, D. (1998). Occurrence and possible mechanisms of cleavage site insertions in the avian influenza hemagglutinin gene. In Proceedings of the 4th International Symposium on Avian Influenza. Athens, Georgia, USA, pp. 182–193
Perroncito, E. (1878). Epizoozia tifoide nei gallinacei. Annals of the Academy of Agriculture, 21, 87–93
Petersen, L. R., & Roehrig, J. T. (2001). West Nile Virus: A reemerging global pathogen. Emerging Infectious Disease, 7(4), 611–614
Potter, C. W. (2001). A history of influenza. Journal of Applied Microbiology, 91, 572–579
Puzelli, S., Di Trani, L., Fabiani, C., Campitelli, L., De Marco, M. A., Capua, I, Aguilera, J. F., Zambom, M., & Donatelli, I. (2005). Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. Journal of Infectious Diseases, 192, 1318–1322
Rappuoli, R., Miller, H. I., & Falkow, S. (2002). The intangible value of vaccines. Science, 297, 937–939
Reid, A. H., Fanning, T. G., Janczewski, T. A., Lourens, R. M., & Tanbenberger, J. K. (2004). Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. Journal of Virology, 78, 12462–12470
Roberts, B. E., & Lu, Y. (2004). Infectious Diseases in Asia: Implications for Global Health in Aids in Asia (Lu, Y. & Essex, M., Eds), Kluwer/Plenum, New York
Rogers, G. N., Paulson, J. C., Daniels, R. S., Skehel, J. J., Wilson, I. A., & Wiley, D. C. (1983). Single amino acid substitutions in influenza haemagglutinin change receptor specificity. Nature, 304, 76–78
Rohm, C., Horimoto, T., Kawaoka, Y., Suss, J., & Webster, R. G. (1995). Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology, 209, 664–670
Rojas, H., Moreira, R., Avalos, P., & Marangon, S. (2002). Avian influenza in poultry in Chile. Veterinary Record, 151, 188
Scholtissek, C., & Murphy, B. R. (1978). Host range mutants of an influenza A virus. Archives of Virology, 58, 323–333
Shaw, M. W., Xu, X., Normand, S., Ueki, R. T., Kumimoto, G. Y., Hall, H, Kimov, A., Cox, N. J., & Subbarao, K. (2002). Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000–2001 and 2001–2002 seasons. Virology, 303, 1–8
Shinya, K., Ebinall, M., Shinya, Y., Ono, M., Kasai, N., & Kawaoka, Y. (2006). Influenza virus receptors in the human airway. Nature, 440, 435–436
Shope, R. E. (1931). Swine influenza filtration experiments and etiology. Journal of Experimental Medicine, 54, 373–385
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997). The impact of influenza epidemics on mortality: Introducing a severity index. American Journal of Public Health, 87, 1944–1950
Simonsen, L., Clarke, M. J., Schonberger, L. B., et al. (1998). Pandemic versus epidemic influenza mortality: A pattern of changing age distribution. Journal of Infectious Diseases, 178, 53–60
Slepushkin, V.A., Katz, J.M., Black R.A., Gamble, W.A., Rota, P.A., & Cox, N.J. (1995). Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13(15) 1399–1402
Smith, W., Andrews, C. H., & Laidlaw, P. P. (1933). A virus obtained from influenza patients. Lancet, 2, 66–68
Steinhauer, D. A. (1999). Minireview role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology, 258, 1–20
Stevens, J., Blixt, O, Tumpey, T. M., Taubenberger, J. K., Paulson, J. C., & Wilson, I. A. (2006). Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Sciencexpress Research article, http://www.sciencexpress.org, 20 March 2006
Sturm-Ramirez, K. M., Hulse-Post, D. J., Govorkova, E. A., Humberd, J., Seiler, P., Puthavathana, P., Buranathai, C., Nguyen, T. D. Chaisingh, A., Long, H. T., Naipospos, T. S. P., Chen, H., Ellis, T. M., Guan, Y., Peiris, J. S. M., & Webster, R. G. (2005). Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? Journal of Virology, 79, 11269–11279
Sugrue, R. J., & Hay, A. J. (1991). Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology, 180, 617–624
Szucs, T. (1999). The socio-economic burden of influenza. The Journal of Antimicrobial Chemotherapy, 44, Topic B, 11–15
Tilman, D. (1999). Global environmental impacts of agricultural expansion: The need for sustainable and efficient practices. Proceedings of the National Academy of Sciences of the United States of America, 96, 5995–6000
Treanor, J. J., Snyder, M. H., London, W. T., & Murphy, B. R. (1989). The B allele of the NS gene of avian influenza viruses but not the A allele attenuates a human influenza A virus for squirrel monkeys. Virology, 171, 1–9
Treanor, J. J., Tierney, E. L., Zebedee, S. L., Lamb, R. A., & Murphy, B. R. (1990). Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. Journal of Virology, 64, 1375–1377
Uiprasertkul, M., Puthavathana, P., Sangsiriwut, K., Pooruk, P., Srisook, K., Peiris, M., Nicholls, J. M., Chokephaibulkit, K., Vanprapar, N., & Auewarakul, P. (2005). Influenza A H5N1 replication sites in humans. Emerging Infectious Diseases, 11, 1036–1041
United Nations. (2004). World Population Prospects: The 2004 Revision. United Nations, New York
Van Riel, D., Munster, V. J. deWit, E. Rimmelzwaan, G. F., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Kuiken, T. (2006). H5N1 virus attachment to lower respiratory tract. Sciencexpress Brevia, http://www.sciencexpress.org, 23 March 2006
Vijayanand, P., Wilkins, E., & Woodhead, M. (2004). Severe acute respiratory syndrome (SARS): A review. Clinical Medicine, 4, 152–160
Villarreal, C. L., & Flores, A. O. (1997). The Mexican avian influenza H5N2 outbreak. In Proceedings of the International Symposium on Avian Influenza American Association of Avian Pathologists, Pennsylvania, Athens, Georgia, USA, pp. 18–22
Webby, R. J., Swenson, S. L., Krauss, S. L., Gerrish, P. J., Goyal, S. M., & Webster, R. G. (2000). Evolution of swine H3N2 influenza viruses in the United States. Journal of Virology 74, 8243–8251
Webster, R. G., & Kawaoka, Y. (1988). Avian influenza. Critical Reviews in Poultry Biology, 1, 211–246
Webster, R. G., & Laver W. G. (1972). The origin of pandemic influenza. Bulletin of the World Health Organization, 47, 449–452
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiological Reviews, 56, 152–179
Weiss, R. A., & McMichael, A. J. (2004). Social and environmental risk factors in the emergence of infectious diseases. Nature Medicine, 10(Suppl. 12), S70–S76
Wood, J. M. (2001). Developing vaccines against pandemic influenza. Philosophical Transactions of the Royal Society of London. Series B, 356, 1953–1960
World Health Organization. (1999). Influenza Pandemic Preparedness Plan. The Role of WHO and Guidelines for National and Regional Planning. WHO, Geneva
World Health Organization. (2003). Influenza Fact Sheet #211, revised March 2003 WHO, Geneva
Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. (2005). Avian influenza A (H5N1) infections in humans. New England Journal of Medicine, 353, 1374–1385
Zebedee, S. L., & Lamb, R. A. (1988). Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of Virology, 62, 2762–2772
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Roberts, B. (2008). Influenza: Biology, Infection, and Control. In: Lu, Y., Essex, M., Roberts, B. (eds) Emerging Infections in Asia. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-75722-3_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-75722-3_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-75721-6
Online ISBN: 978-0-387-75722-3
eBook Packages: MedicineMedicine (R0)